Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study-Reference-Cited by-同舟云学术

Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study

Published:2015-08-12 Issue:2 Volume:24 Page:945-952
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Seol Young Mi,Kim Hyo Jeong,Choi Young Jin,Lee Eun Mi,Kim Yang Soo,Oh Sung Yong,Koh Su Jin,Baek Jin Ho,Lee Won Sik,Joo Young Don,Lee Hyun Gi,Yun Eun Young,Chung Joo Seop

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00520-015-2865-8.pdf

Reference19 articles.

1. Griffin AM, Butow PN, Coates AS, et al (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189–195

2. Almeida EP, Gutierrez MG, Adami NP (2004) Monitoring and evaluation of side effects of chemotherapy in patients with colon cancer. Rev Lat Am Enfermagem 12:760–766

3. Andrews PL, Sanger GJ (2002) Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr Opin Pharmacol 2:650–656

4. Fukui H, Yamamoto M, Sato S (1992) Vagal afferent fibers and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs. Jpn J Pharmacol 59:221–226

5. Balfour JA, Goa KL (1997) Dolasetron. A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy, radiotherapy or surgery. Drugs 54:273–298

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese expert consensus on prevention and treatment of delayed nausea and vomiting (2022 Edition);Oncology and Translational Medicine;2023-08

2. Efficacy of the granisetron transdermal system for the control of nausea and vomiting induced by highly emetogenic chemotherapy: a multicenter, randomized, controlled trial;The Korean Journal of Internal Medicine;2023-05-01

3. Prophylaxe von Übelkeit und Erbrechen nach medikamentöser Tumortherapie;Die Urologie;2022-06

4. Antiemetics for adults for prevention of nausea and vomiting caused by moderately or highly emetogenic chemotherapy: a network meta-analysis;Cochrane Database of Systematic Reviews;2021-11-16

5. Effectiveness of palonosetron versus granisetron in preventing chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis;European Journal of Clinical Pharmacology;2021-05-15